The Biden administration is trying to close a gap in the Affordable Care Act that blocks 5 million people from getting affordable health care.
Federal Policy
The Sky-High Price of Insulin and What Lawmakers Are Trying To Do About It
We explore the high cost of insulin in the U.S. and Congress’ latest push to address those prices with Kaiser Health News reporter Bram Sable-Smith. d
How One Alzheimer’s Drug Is Changing the U.S. Drug Approval Conversation
Taking stock of the impact of the Aduhelm saga and Medicare’s decision to restrict coverage of the controversial treatment.
Are Veterans Less Likely to Die at VA Hospitals?
Amal Trivedi shares research looking at what happens to veterans who get emergency care at VA vs. non-VA hospitals.
Health Care’s Climate Change Contradiction
We explore health care’s role in the climate crisis and what policies are needed to shrink its carbon footprint.
What Happened When COVID Eased Methadone Restrictions?
Leslie Suen writes about new research suggesting loosened methadone regulations have not led to more overdoses or drug sales as many have long feared.
The FDA Super Bowl
We break down the controversial FDA user fee process and the legislative bonanza it kicks off every five years.
Answering the Call, Part 1: America’s New Mental Health Crisis Line
A new nationwide crisis line launches in July 2022. Will it be ready to meet America’s mental health needs?
Harm Reduction’s Road From Fringe to Federal Drug Policy
How a once taboo strategy to keep drug users safe has become more mainstream and what that could mean for our overdose crisis.
How Immigration Enforcement Can Affect Newborns’ Health
Sebastian Tello-Trillo shares research on the impact of immigration enforcement fears on babies born to undocumented parents.
